FGF-21 as a Potential Mediator for the Antidepressant Effects of Physical Exercise

被引：1
|
作者：
Liu, Yan
Yau, Suk Yu
Wang, Yao
Xu, Aimin
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-2249-PUB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Letter to the Editor: Potential Role for FGF21 as a Mediator of Thyroid Hormone Effects on Metabolic Regulation
    Bonde, Ylva
    Angelin, Bo
    Rudling, Mats
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (12): : L130 - L131
  • [32] The stimulatory effects of glucagon on cortisol and GH secretion occur independently from FGF-21
    Ilyas Akkar
    Zuleyha Karaca
    Serpil Taheri
    Kursad Unluhizarci
    Aysa Hacioglu
    Fahrettin Kelestimur
    Endocrine, 2022, 75 : 211 - 218
  • [33] The stimulatory effects of glucagon on cortisol and GH secretion occur independently from FGF-21
    Akkar, Ilyas
    Karaca, Zuleyha
    Taheri, Serpil
    Unluhizarci, Kursad
    Hacioglu, Aysa
    Kelestimur, Fahrettin
    ENDOCRINE, 2022, 75 (01) : 211 - 218
  • [34] Fibroblast Growth Factor-21 (FGF-21) predicts development of diabetes and pioglitazone attenuates the increase in FGF-21 in subjects with IGT: results from the ACTNOW study
    Tripathy, D.
    Alonzo, R. P.
    Chavez-Velazquez, A.
    Martinez, R.
    Musi, N.
    Defronzo, R.
    DIABETOLOGIA, 2016, 59 : S164 - S164
  • [35] Elevated FGF-21 during Circadian Misalignment in Healthy Humans
    Broussard, Josiane L.
    Morton, Sarah J.
    Markan, Kathleen
    Mchill, Andrew W.
    Higgins, Janine
    Melanson, Edward
    Wright, Kenneth, Jr.
    DIABETES, 2019, 68
  • [36] Enhancement of the Pharmacological Efficacy of FGF-21 by Genetic Modification and PEGylation
    Ye, Xianlong
    Qi, Jianying
    Sun, Guopeng
    Ren, Guiping
    Zhu, Shenglong
    Wu, Yunzhou
    Yu, Dan
    Zhao, Jingzhuang
    Liu, Mingyao
    Li, Deshan
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2013, 14 (15) : 1287 - 1298
  • [37] Use of FGF-21 as a Biomarker of Mitochondrial Disease in Clinical Practice
    Morovat, Alireza
    Weerasinghe, Gayani
    Nesbitt, Victoria
    Hofer, Monika
    Agnew, Thomas
    Quaghebeur, Geralrine
    Sergeant, Kate
    Fratter, Carl
    Guha, Nishan
    Mirzazadeh, Mehdi
    Poulton, Joanna
    JOURNAL OF CLINICAL MEDICINE, 2017, 6 (08):
  • [38] Serum FGF-21 Levels in Type 2 Diabetic Patients
    Cheng, Xingbo
    Zhu, Bei
    Jiang, Fusong
    Fan, Huaying
    ENDOCRINE RESEARCH, 2011, 36 (04) : 142 - 148
  • [39] Next Generation of FGF-21 Analogs: Engineered Short-and Long-Acting FGF-21 Variants with Improved In Vivo Potency, Stability, and Biopharmaceutical Properties
    Gonciarz, Malgorzata
    Driver, David
    Dickinson, Craig D.
    Ford, Amy
    Morehead, Teresa A.
    Dunbar, James D.
    Baker, Hana E.
    O'Farrell, Libbey S.
    Murphy, Anthony T.
    Hansen, Ryan J.
    Adams, Andrew C.
    Coskun, Tamer
    Darling, Ryan
    DIABETES, 2017, 66 : A530 - A530
  • [40] FGF-21: promising biomarker for detecting ketosis in dairy cows
    Xu, Chuang
    Xu, Qiushi
    Chen, Yuanyuan
    Yang, Wei
    Xia, Cheng
    Yu, Hongjiang
    Zhu, Kuilin
    Shen, Taiyu
    Zhang, Ziyang
    VETERINARY RESEARCH COMMUNICATIONS, 2016, 40 (01) : 49 - 54
12345